Pelvic malignant mixed mesodermal tumor of uncertain origin: A case report

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 83, Issue 2, 1999, Pages 227-231

  Arai, Yuko ^a   Oka, Kuniyuki ^a   Hakozaki, Hando ^b   Koyamatsu, Sumiko ^a   Tobita, Tomomi ^a   Okane, Masato ^a   Nishida, Masato ^c   Kubo, Takeshi ^c   Mukai, Kiyoshi ^d   Mori, Naoyoshi ^e  

^a Mito Saiseikai General Hospital   (Japan)

^b FUKUSHIMA ROSAI HOSPITAL   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenocarcinoma; Chondrosarcoma; Endometrial Stromal Sarcoma; Malignant Mixed Mesodermal (Mullerian) Tumor; Pelvic Tumor; Pleomorphic Sarcoma

Indexed keywords

ALPHA 1 ANTITRYPSIN; CISPLATIN; ETOPOSIDE;

ADENOCARCINOMA; ADULT; ARTICLE; CASE REPORT; FEMALE; GIANT CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MIXED TUMOR; MORPHOLOGY; PELVIS CANCER; PRIORITY JOURNAL; SARCOMA;

EID: 0032962405     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-2115(99)00004-4     Document Type: Article

References (11)

1. Silverberg SG, Kurman RJ. Carcinosarcoma. In: Atlas of Tumor Pathology: Tumors of the Uterine Corpus and Gestational Trophoblastic Disease, 3rd Series. Fascicle 3. Washington D.C., Armed Forces Institute of Pathology, 1992:166-77.
2. Garde J.R., Jones M.A., McAfee R., Tarraza H.M. Extragenital malignant mixed müllerian tumor: Review of the literature. Gynecol Oncol. 43:1991;186-190.
3. Nimaroff M., Gal D., Susin M., Lovecchio J. Extragenital malignant mixed müllerian tumor. Eur J Gynaecol Oncol. 14:1993;23-27.
4. Mira J.L., Fenoglio-Preiser C.M., Husseinzadeh N. Malignant mixed Müllerrian tumor of the extraovarian secondary müllerian system: Report of two cases and review of the English literature. Arch Pathol Lab Med. 119:1995;1044-1049.
5. Clement P.B., Young R.H., Scully R.E. Chapter 8 Peritoneum. Sternberg S.S., Mills S.E. Surgical Pathology of the Female Reproductive System and Peritoneum. 1991;280 Raven Press, New York.
6. Rusch V.W. Meeting report - a proposed new international TNM staging system for malignant pleural mesothelioma from the International Mesothelioma Interest Group. Lung Cancer. 14:1996;1-12.
7. Du BouLay C.E.H. Demonstration of alpha-1-antitrypsin and alpha-1-antichymotrypsin in fibrous histiocytomas using immunoperoxidase technique. Am J Surg Pathol. 6:1982;559-605.
8. Enzinger F.M., Weiss S.W. Chapter 11 Malignant fibrohistiocytic tumors. Soft Tissue Tumors. 2nd Edition :1988;269-300 The C.V. Mosby Company, Washington D.C.
9. Chou S.T., Fortune D., Beischer N.A. et al. Primary malignant fibrous histiocytoma of the uterus-ultrastructural and immunocytochemical studies of two cases. Pathology. 17:1985;36-40.
10. Dictor M. Alpha-1-antitrypsin in a malignant mixed mesodermal tumor of the ovary. Am J Surg Pathol. 5:1981;543-550.
11. Lauchlan S. The secondary müllerian system. Obstet Gynecol Surv. 27:1972;133-146.